leukemia Archives
One-two punch for cancer
Mar. 5, 2020—A drug combination effectively killed aggressive blood cancers in cell and animal models; now it’s being tested in patients.
Connecting an asthma gene to leukemia
Aug. 2, 2018—A receptor previously implicated in asthma may also play roles in other allergic diseases and in leukemia, Vanderbilt researchers have discovered.
New cutting-edge treatment for type of pediatric leukemia offered at Monroe Carell Jr. Children’s Hospital at Vanderbilt
Sep. 18, 2017—Monroe Carell Jr. Children’s Hospital at Vanderbilt is part of a select group of health care institutions recently chosen to offer a new FDA-approved immunotherapy for a subset of pediatric acute lymphoblastic leukemia (ALL). Only 32 health care institutions in the United States will be certified to offer the therapy. Vanderbilt is only one of...
Restore T cells to fight leukemia
Sep. 14, 2016—Modulation of T cell metabolism thus may represent a new therapeutic avenue for leukemia patients.
Medical staff, theater join forces to help cancer patient see ‘Star Wars’
Jan. 21, 2016—A Vanderbilt patient who has battled leukemia for nearly five years was granted a private screening of “Star Wars: The Force Awakens,” thanks to her medical providers and a local movie theater.
Pet Therapy Research Aimed at Children with Cancer
Jun. 5, 2014—It’s not unusual to see dogs in a hospital setting, but is there scientific evidence that man’s best friend help’s children? Vanderbilt researchers are working to find that answer as Barb Cramer reports.
Probing the pathogenesis of leukemia
Feb. 27, 2014—A new mouse model reveals gene clusters important in a treatment-resistant form of leukemia.
Hyundai award helps drive hope for cancer research
Sep. 19, 2013—Emmanuel Volanakis, M.D., assistant professor of Pediatrics and Hematology/Oncology, was awarded a $250,000 Hyundai Hope On Wheels grant last week for his ongoing research into T-cell acute lymphoblastic leukemia (ALL), an aggressive blood cancer.
Leukemia & Lymphoma Society honors Ohi’s research
Jun. 6, 2013—Puck Ohi, Ph.D., assistant professor of Cell and Developmental Biology, has received the Leukemia & Lymphoma Society SCHOLAR award for his research on the role of enzymes that affect cell division, which has implications for treating cancer and blood disorders like leukemia and lymphoma.
Leukemia culprit’s cellular actions
Apr. 11, 2013—Overexpression of a gene that is a common culprit in leukemia induces stem cell-like features in T cells, which may enable the cells to become cancerous.
